Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Nov;24(6):689-697.
doi: 10.1016/j.jsps.2015.06.004. Epub 2015 Jun 16.

A pragmatic approach to the analysis of a combination formulation

Affiliations

A pragmatic approach to the analysis of a combination formulation

Noshin Mubtasim et al. Saudi Pharm J. 2016 Nov.

Abstract

The aim of the paper was to formulate a combined oral dosage form of rosuvastatin calcium and amlodipine besylate and to develop and validate an analytical method to be adopted for both routine quality control assay and in vitro dissolution studies of the formulation. The proposed combination formulation has shown compatibility with the chosen excipients, verified through FT-IR study. A novel gradient RP-HPLC method was developed and validated according to the ICH guideline which was found to be suitable for the simultaneous estimation of rosuvastatin calcium and amlodipine besylate from the formulation. The retention time of 2.7 and 6.08 min allows the analysis of large amount of samples with less mobile phase which makes the method economic. The dissolution profiles of both the drugs in different dissolution medium were encouraging which makes the combination formulation of rosuvastatin calcium and amlodipine besylate superior and effective in achieving patient compliance.

Keywords: % RSD, percentage relative standard deviation; Amlodipine besylate; BP, British Pharmacopeia; CVD, cardiovascular disease; Ca2+, calcium; Combination formulation; Compatible; FDA, Food and Drug Administration; FT-IR, Fourier Transform Infrared spectroscopy; HMG-CoA, 3-hydroxy-3-methylglutaryl coenzyme-A; ICH, International Conference on Harmonization; IR, infrared; LC, liquid chromatography; LOD, limit of detection; LOQ, limit of quantitation; Method validation; PDA, photo diode array; RP-HPLC, reverse phase high performance liquid chromatography; Rosuvastatin calcium; THF, tetrahydrofuran; USP, United States Pharmacopeia; ml, milliliter; μg, microgram; μl, microliter.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Structure of rosuvastatin calcium.
Figure 2
Figure 2
Structure of amlodipine besylate.
Figure 3
Figure 3
FT-IR study of rosuvastatin calcium standard.
Figure 4
Figure 4
FT-IR study of amlodipine besylate standard.
Figure 5
Figure 5
Chromatogram of rosuvastatin calcium and amlodipine besylate reference standard.
Figure 6
Figure 6
Calibration curve of rosuvastatin calcium.
Figure 7
Figure 7
Calibration curve of amlodipine besylate.
Figure 8
Figure 8
Comparative drug release pattern of rosuvastatin calcium and amlodipine besylate.
Figure 9
Figure 9
Flowchart of the study design.

References

    1. Atram S.C., et al. Formulation of bilayer tablet containing metoprolol succinate and amlodipine besylate as a model drug for antihypertensive therapy. J. Pharm. Res. 2009;2(8):1335–1347.
    1. Banerjee S.K., Vasava N.M. Simultaneous estimation of Amlodipine and Rosuvastatin in combined bulk forms by RP-HPLC using Ultraviolate detection. Bull. Pharm. Res. 2013;3(1):29–33.
    1. Bashir S., et al. Efficacy of fix dose combination (atorvastatin and amlodipine) in treatment of uncontrolled hypertension and dyslipidemia. Pubmed. 2011;23(3):97–100. - PubMed
    1. Blank R., et al. Single-Pill therapy in the treatment of concomitant hypertension and dyslipidemia (the amlodipine/atorvastatin Gemini study) J. Clin. Hypertens. 2005;7(5):264–273. - PMC - PubMed
    1. Drug information reference, 2003. Calcium channel blocking drugs. pp. 192–198. <http://dpic.org/sites/default/files/pdf/DIR_CCBs.pdf> (accessed 08.04.15).

LinkOut - more resources